Investing.com - Brainstorm Cell Therapeutics (NASDAQ:BCLI) reported on Monday third quarter earnings that missed analysts' forecasts and revenue that was in line with...
Brainstorm Cell Therapeutics (BCLI) reported Q3 EPS of ($0.53), $0.35 worse than the analyst estimate of ($0.18).
1. Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics (NASDAQ:BCLI) on Wednesday was up a small fraction, gaining 35 cents, or 2.8%, to 12.83 on 1.4 million shares traded....
1. Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics (NASDAQ:BCLI) on Wednesday was up a small fraction, gaining 35 cents, or 2.8%, to 12.83, with an early morning high of...
Neuroderm Ltd (NASDAQ:NDRM) was up 1.55, or 5.8%, to 28.10, on 512,288 shares traded on Monday. It popped through the double-top at the resistance level after falling out of a...
Brainstorm Cell Therapeutics Inc. is a biotechnology company. The Company is focused on the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases, including Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), Alzheimer's disease (AD), and other neurodegenerative diseases. NurOwn, its cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells (MSCs) to secrete high levels of neurotrophic factors (NTFs), modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival and improve neurological function. NurOwn has completed its phase III ALS and phase II PMS clinical trials. Its wholly owned subsidiary, BrainStorm Cell Therapeutics Ltd. holds the rights to commercialize its NurOwn technology. Its other subsidiaries include Advanced Cell Therapies Ltd., and two others.
|Average||7.000 (+341.640% Upside)|
|No. of Analysts||2|
|Moving Averages||Strong Buy||Strong Buy||Buy||Sell||Strong Sell|
|Technical Indicators||Strong Buy||Buy||Sell||Strong Sell||Strong Sell|
|Summary||Strong Buy||Strong Buy||Neutral||Strong Sell||Strong Sell|